Medicine Grand Rounds: Felicia Cosman, Professor of Clinical Medicine, Columbia University, “Optimal Treatment Strategies for Patients at High Risk of Fracture”

Felicia Cosman is Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons and Medical Director of the National Osteoporosis Foundation.

Dr. Cosman’s research includes studies on the causes of osteoporosis and how estrogen, SERMs, vitamin D, bisphosphonates, denosumab, and anabolic therapies work as treatments for osteoporosis. She has also studied the causes of stress fractures and factors influencing the acquisition of peak bone mass during youth, as well as identifying patient factors, which should prompt targeted screening for vertebral fractures. A major research focus over the last decade has been on the use of bone-building medications (teriparatide, abaloparatide and romosozumab).  She is a major thought leader in studies of treatment sequences and combinations, long-term treatment paradigms and goal-directed osteoporosis therapy.

Dr. Cosman is the recipient of multiple research grants from the NIH, the Department of Defense, the National Multiple Sclerosis Society, and multiple pharmaceutical companies. She has published more than 150 peer-reviewed articles in the field of osteoporosis. Most recently, she was selected as Editor-in-Chief of the journal Osteoporosis International.
Watch the video